304
Participants
Start Date
August 27, 2019
Primary Completion Date
December 9, 2020
Study Completion Date
December 9, 2020
gadopiclenol
Single intravenous bolus injection
Gadobutrol 1 MMOLE/ML Intravenous Solution
Single intravenous bolus injection
Montefiore Medical Center, The Bronx
The University of Alabama at Birmingham, Birmingham
The University of Chicago Medical Center, Chicago
University of Missouri Health System, Columbia
UT Health San Antonio, San Antonio
UConn Health - University of Connecticut, Farmington
Boston Medical Center, Boston
Acibadem City Clinic Tokuda Hospital Sofia, Sofia
CHU, Angers
CHU Beaujon, Clichy
Hôpital Saint Louis, Paris
Klinik für Diagnostische und Interventionelle Radiologie, Aachen
Universitätsklinikum Halle, Halle
Universitätsklinikum des Saarlandes, Homburg
University Hospital Jena, Jena
Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvár
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok
"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale", Napoli
Clinical Research Institute S.C., Estado de México
Axis Heilsa S de R.L. de C.V - Althian Clinical Research Management Center, Monterrey
Szpital Uniwersytecki Nr 1 im. dr Antoniego Jurasza w Bydgoszczy, Bydgoszcz
Uniwersyteckie Centrum Kliniczne, Gdansk
Jagiellońskie Centrum Innowacji Sp. z o. o., Krakow
Szpital Świętego Rafała, Krakow
Centrum Medyczne Affidea Wałbrzych, Wałbrzych
Inje University Busan Paik Hospital, Busan
Bucheon Suncheonhyang Hospital, Gyeonggi-do
Korea University Anam Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Hospital Universitario y Politécnico La Fe, Valencia
St. Luke's Hospital, Kropyvnytskyi
Borys Clinic, Kyiv
Lead Sponsor
Guerbet
INDUSTRY